Table 4.
Results of the external validation for DF.
| Active Group | Inactive Group | ||||||
|---|---|---|---|---|---|---|---|
| Compound | DF | Prob. a Active |
Predicted Activity b | Compound | DF | Prob. a Inactive |
Predicted Activity b |
| Morphazinamide | 4.32 | 1.000 | + | Canthaxanthin | −3.46 | 1.000 | − |
| Neomycin | 5.02 | 1.000 | + | Genite | −2.57 | 1.000 | − |
| Tubercidin | 2.85 | 0.999 | + | Altretamine | −1.91 | 0.997 | − |
| Ciprofloxacin | 2.15 | 0.995 | + | Etifoxin | −1.86 | 0.997 | − |
| Viomycin | 1.75 | 0.986 | + | Dichlone | −1.78 | 0.996 | − |
| Rifabutin | 0.73 | 0.799 | + | Feprazone | −1.47 | 0.991 | − |
| Ethionamide | −1.30 | 0.014 | − | Antipyrine | −0.44 | 0.868 | − |
| Benorylate | −0.25 | 0.792 | − | ||||
| Chloropal | 0.19 | 0.526 | NC | ||||
| Glucosamine | 1.77 | 0.014 | + | ||||
a Prob., probability; b When probability active or probability inactive > 0.60, the compound is classified as active “+” or inactive “−”, respectively. In any other case, the compound is considerate non-classified “NC”.